Log In
BCIQ
Print this Print this
 

IPX203

  Manage Alerts
Collapse Summary General Information
Company Impax Laboratories Inc.
DescriptionUndisclosed
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard IndicationParkinson's disease (PD)
Indication DetailsTreat Parkinson's disease (PD)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today